Mihir Bhatt, MD, MSc

Department of Pediatrics
McMaster Children’s Hospital, McMaster University, Hamilton, Canada
Hamilton, Ontario, Canada

Dr. Mihir Bhatt completed his MD, residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at McMaster University. He is a working as a staff Pediatric Hematologist/Oncologist since 2017. He has a special research interest in pediatric hemostasis and thrombosis. He was involved in DOAC trials in neonates and children, and has recently completed pilot prospective multicenter randomized controlled trial examining the utility of monitoring antithrombotic therapy in neonates and children.

Presentation(s):

• OC 06.1 - A pilot feasibility and safety multicenter trial of administering weight adjusted fixed dose of low molecular weight heparin (enoxaparin) to neonates and children with thrombosis (FIXET)

  Saturday, June 22, 2024
  13:00 – 13:15 ICT

• OC 06.3 - Safety and efficacy of anticoagulation therapy in pediatric patients with solid tumours or lymphomas at risk of thrombocytopenia: a retrospective study

  Saturday, June 22, 2024
  13:30 – 13:45 ICT

• PB0623 - A comprehensive review of low-molecular-weight-heparin anticoagulation therapy dose management in pediatric patients at risk of thrombocytopenia

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 65.3 - Prognostic factors for complete and partial veno-occlusion following an initial six weeks of anticoagulant therapy for first-episode provoked venous thromboembolism (VTE) in patients < 21 years

  Tuesday, June 25, 2024
  15:15 – 15:30 ICT